Doo-Hun Kim
Vermogen: 149 502 $ op 31-05-2026
Vermogen: 149 502 $ op 31-05-2026
Doo-Hun Kim currently works at Feyman Asset Management Co., Ltd., as Chief Executive Officer and AbClon, Inc., as Chief Financial Officer & Executive Director from 2024.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ABCLON, INC. 0,03% | 27-04-2026 | 6.000 ( 0,03% ) | 149 502 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ABCLON INC. | Financieel Directeur/CFO | 28-03-2024 |
Feyman Asset Management Co., Ltd.
Feyman Asset Management Co., Ltd. Investment ManagersFinance FAM is an active, GARP-oriented, team-based investment manager which concentrates on high-performance stock in the electronics, finance, chemical, iron/steel manufacturing and transportation equipment manufacturing industries. The firm primarily manages stock/bond combination funds and money market funds. They apply a combination of bottom-up and top-down approaches in the composition of portfolios, and consider both value and growth firms. In addition, industry-specific analysis takes up an important role, while risk management is achieved through sector-rotating and evaluation against a benchmark. | Algemeen Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 2 |
|---|---|
Feyman Asset Management Co., Ltd.
Feyman Asset Management Co., Ltd. Investment ManagersFinance FAM is an active, GARP-oriented, team-based investment manager which concentrates on high-performance stock in the electronics, finance, chemical, iron/steel manufacturing and transportation equipment manufacturing industries. The firm primarily manages stock/bond combination funds and money market funds. They apply a combination of bottom-up and top-down approaches in the composition of portfolios, and consider both value and growth firms. In addition, industry-specific analysis takes up an important role, while risk management is achieved through sector-rotating and evaluation against a benchmark. | Finance |
AbClon, Inc.
AbClon, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of antibody drugs | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau